These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 30784225)
21. Exendin-4 promotes bone formation in diabetic states via HDAC1-Wnt/β-catenin axis. Deng Y; Zhu W; Anhua Lin ; Wang C; Xiong C; Xu F; Li J; Huang S; Zhang N; Huo Y Biochem Biophys Res Commun; 2021 Mar; 544():8-14. PubMed ID: 33516884 [TBL] [Abstract][Full Text] [Related]
22. Effects of Transplanting Bone Marrow Stromal Cells Transfected with CXCL13 on Fracture Healing of Diabetic Rats. Jiang H; Wang Y; Meng J; Chen S; Wang J; Qiu Y; Zhao J; Guo T Cell Physiol Biochem; 2018; 49(1):123-133. PubMed ID: 30134225 [TBL] [Abstract][Full Text] [Related]
23. Synergistic effects of recombinant Lentiviral-mediated BMP2 and TGF-beta3 on the osteogenic differentiation of rat bone marrow mesenchymal stem cells in vitro. He W; Chen L; Huang Y; Xu Z; Xu W; Ding N; Chen J Cytokine; 2019 Aug; 120():1-8. PubMed ID: 30991228 [TBL] [Abstract][Full Text] [Related]
24. Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets. Zhang W; Zhou L; Dang J; Zhang X; Wang J; Chen Y; Liang J; Li D; Ma J; Yuan J; Chen W; Zadeh HH; Olsen N; Zheng SG Sci Rep; 2017 Nov; 7(1):15249. PubMed ID: 29127315 [TBL] [Abstract][Full Text] [Related]
25. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909 [TBL] [Abstract][Full Text] [Related]
26. Comparative study on the therapeutic effects of bone marrow mesenchymal stem cells versus platelet rich plasma on the pancreas of adult male albino rats with streptozotocin-induced type 1 diabetes mellitus. El-Haroun H; Salama RM Folia Morphol (Warsz); 2022; 81(1):65-81. PubMed ID: 33559114 [TBL] [Abstract][Full Text] [Related]
27. The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model. Wang X; Wang C; Gou W; Xu X; Wang Y; Wang A; Xu W; Guo Q; Liu S; Lu Q; Meng H; Yuan M; Peng J; Lu S Stem Cell Res Ther; 2018 Oct; 9(1):272. PubMed ID: 30359311 [TBL] [Abstract][Full Text] [Related]
28. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells. Guang LG; Boskey AL; Zhu W Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988 [TBL] [Abstract][Full Text] [Related]
29. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts. Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215 [TBL] [Abstract][Full Text] [Related]
30. Normoglycemia partially recovers the disrupted osteoblast differentiation of mesenchymal stem cells induced by type 1 but not type 2 diabetes mellitus. Weffort D; Adolpho LF; Souza ATP; Freitas GP; Lopes HB; Oliveira FS; Bighetti-Trevisan RL; Pitol-Palin L; Matsushita DH; Okamoto R; Beloti MM; Rosa AL J Cell Biochem; 2023 Jul; 124(7):1050-1063. PubMed ID: 37293736 [TBL] [Abstract][Full Text] [Related]
31. [Semaphorin 3A-stimulated bone marrow mesenchymal stem cells sheets promotes osteogenesis of type 2 diabetic rat]. Qiao Q; Song YL; Li FL Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 May; 53(5):333-338. PubMed ID: 29972992 [No Abstract] [Full Text] [Related]
32. Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes. Diao TY; Pan H; Gu SS; Chen X; Zhang FY; Wong MS; Zhang Y J Bone Miner Metab; 2014 May; 32(3):261-70. PubMed ID: 23934056 [TBL] [Abstract][Full Text] [Related]
33. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. Luu HH; Song WX; Luo X; Manning D; Luo J; Deng ZL; Sharff KA; Montag AG; Haydon RC; He TC J Orthop Res; 2007 May; 25(5):665-77. PubMed ID: 17290432 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow mesenchymal stem cells derived exosomal miRNAs can modulate diabetic bone-fat imbalance. Han F; Wang C; Cheng P; Liu T; Wang WS Front Endocrinol (Lausanne); 2023; 14():1149168. PubMed ID: 37124755 [TBL] [Abstract][Full Text] [Related]
36. Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. Hamada Y; Fujii H; Kitazawa R; Yodoi J; Kitazawa S; Fukagawa M Bone; 2009 May; 44(5):936-41. PubMed ID: 19146996 [TBL] [Abstract][Full Text] [Related]
37. Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. Kugimiya F; Kawaguchi H; Kamekura S; Chikuda H; Ohba S; Yano F; Ogata N; Katagiri T; Harada Y; Azuma Y; Nakamura K; Chung UI J Biol Chem; 2005 Oct; 280(42):35704-12. PubMed ID: 16109715 [TBL] [Abstract][Full Text] [Related]
38. Effect of 28 days treatment of baricitinib on mechanical allodynia, osteopenia, and loss of nerve fibers in an experimental model of type-1 diabetes mellitus. Acosta-González RI; Hernández-Jiménez AY; Ramírez-Quintanilla LY; Torres-Rodríguez HF; Vargas Muñoz VM; Jiménez-Andrade JM Pharmacol Rep; 2024 Oct; 76(5):1079-1088. PubMed ID: 39155357 [TBL] [Abstract][Full Text] [Related]